rethinkTHC Search
Menu
Study breakdown

Florida Medical Cannabis Patients Use It Primarily for Anxiety, Pain, and Depression, With Most Reporting Improvement

Cross SectionalModerate evidence
The takeaway

In a survey of 632 Florida medical cannabis patients, the top reasons for use were anxiety (61%), chronic pain (44%), and depression (40%), with 95-98% reporting improvement in these conditions, though many used it for reasons beyond their qualifying conditions.

Medical cannabis program administrators, cannabis prescribers, health policy researchers

95-98% reported improvement for anxiety, depression, and chronic pain

What the researchers found

Top qualifying conditions: PTSD (29.6%), "comparable conditions" (22.2%), chronic pain (25.6%). Top self-reported reasons: anxiety (60.6%), chronic pain (44.0%), depression (39.9%), PTSD (34.8%). Most reported improvement: anxiety (95.3%), depression (97.2%), chronic pain (98.4%), insomnia (86.4%), PTSD (91.5%). ADHD had lowest perceived improvement (66.7%). A notable proportion sought MC for conditions beyond officially qualifying ones.

Why it matters

This study reveals a significant gap between what medical cannabis patients are officially certified for and what they are actually treating. The high self-reported improvement rates, including for conditions with limited evidence, highlight the need for clinical trials to validate or challenge patient experiences.

The numbers in context

632 patients; 62.7% female; median age 45; anxiety 60.6% reason for use; chronic pain 44.0%; depression 39.9%; 95-98% improvement for top conditions; ADHD 66.7% improvement; blood pressure 57.4% unsure/no change.

How the study worked

Cross-sectional survey of 632 medical cannabis patients from 9 Florida MC clinics in 2022, assessing qualifying conditions, self-reported reasons for use, and perceived impacts.

What this study cannot tell us

Convenience sample from 9 clinics may not represent all Florida patients. Self-reported outcomes susceptible to placebo effect and expectancy bias. No control group or objective outcome measures. 2022 data.

How to read the evidence

Large convenience sample with comprehensive survey, limited by self-report bias and no control group.

When this study was published

2024 publication with 2022 data

The bigger picture

Medical cannabis programs are designed around qualifying conditions, but patients are using cannabis for a broader range of symptoms. The disconnect between regulatory frameworks and patient behavior suggests either conditions lists need updating or patient expectations need better management.

Questions still open

  • Do the high self-reported improvement rates hold up in placebo-controlled trials?
  • Should qualifying condition lists be expanded to match actual patient use patterns?

Common questions

What do medical cannabis patients use it for?
In this Florida survey, the top reasons were anxiety (61%), chronic pain (44%), depression (40%), and PTSD (35%). Many patients used cannabis for conditions beyond their official qualifying diagnosis.
Do medical cannabis patients think it works?
Self-reported improvement rates were very high: 98% for chronic pain, 97% for depression, 95% for anxiety, and 91% for PTSD. However, these are subjective reports without placebo controls, so the true therapeutic effect is unknown.

Read the original research

Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.

Medical cannabis and cannabinoids, 7(1), 138-148

Citation

Sajdeya, Ruba; Jugl, Sebastian; Wang, Yan; Perez, Juan G; Maloney, Sophie; Lopez-Quintero, Catalina; Goodin, Amie J; Winterstein, Almut G; Cook, Robert L. (2024). Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.. Medical cannabis and cannabinoids, 7(1), 138-148. https://doi.org/10.1159/000540593

Explore the wider topic